Inventor
RICHARDSON CELESTE
US11 patents
⚠️ This page may combine multiple inventors who share the name “RICHARDSON CELESTE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NOVARTIS AG
7 patentsUS10174095B2Jan 8, 2019
Nucleic acid encoding a humanized anti-BCMA chimeric antigen receptor
NOVARTIS AG41 citations96
US9777061B2Oct 3, 2017
Treatment of cancer using a CD33 chimeric antigen receptor
NOVARTIS AG85 citations96
US11084880B2Aug 10, 2021
Anti-BCMA chimeric antigen receptor
NOVARTIS AG15 citations93
US10568947B2Feb 25, 2020
Treatment of cancer using a CLL-1 chimeric antigen receptor
NOVARTIS AG6 citations71
US12037583B2Jul 16, 2024
Compositions and methods for immunooncology
NOVARTIS AG2 citations67
US12338287B2Jun 24, 2025
Treatment of cancer using a CD33 chimeric antigen receptor
NOVARTIS AG0 citations61
US10851166B2Dec 1, 2020
Treatment of cancer using a CD33 chimeric antigen receptor
NOVARTIS AG1 citations61
OBSIDIAN THERAPEUTICS INC
3 patentsUS11666642B2Jun 6, 2023
PDE5 compositions and methods for immunotherapy
OBSIDIAN THERAPEUTICS INC9 citations81
US11241485B2Feb 8, 2022
PDE5 compositions and methods for immunotherapy
OBSIDIAN THERAPEUTICS INC11 citations81
US11058725B2Jul 13, 2021
CA2 compositions and methods for tunable regulation
OBSIDIAN THERAPEUTICS INC5 citations62